Tatò L - Search Results

1

Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study.

Gatti D, Antoniazzi F, Prizzi R, Braga V, Rossini M, Tatò L, Viapiana O, Adami S. Gatti D, et al. Among authors: tato l. J Bone Miner Res. 2005 May;20(5):758-63. doi: 10.1359/JBMR.041232. Epub 2004 Dec 20. J Bone Miner Res. 2005. PMID: 15824848 Free article. Clinical Trial.

2

Early bisphosphonate treatment in infants with severe osteogenesis imperfecta.

Antoniazzi F, Zamboni G, Lauriola S, Donadi L, Adami S, Tatò L. Antoniazzi F, et al. Among authors: tato l. J Pediatr. 2006 Aug;149(2):174-9. doi: 10.1016/j.jpeds.2006.03.013. J Pediatr. 2006. PMID: 16887429 Free article. Clinical Trial.

3

GH in combination with bisphosphonate treatment in osteogenesis imperfecta.

Antoniazzi F, Monti E, Venturi G, Franceschi R, Doro F, Gatti D, Zamboni G, Tatò L. Antoniazzi F, et al. Among authors: tato l. Eur J Endocrinol. 2010 Sep;163(3):479-87. doi: 10.1530/EJE-10-0208. Epub 2010 Jun 30. Eur J Endocrinol. 2010. PMID: 20592128 Clinical Trial.

4

Intravenous neridronate in adults with osteogenesis imperfecta.

Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tatò L. Adami S, et al. Among authors: tato l. J Bone Miner Res. 2003 Jan;18(1):126-30. doi: 10.1359/jbmr.2003.18.1.126. J Bone Miner Res. 2003. PMID: 12510813 Free article. Clinical Trial.

5

Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.

Antoniazzi F, Radetti G, Zamboni G, Gambaro G, Adami S, Tatò L. Antoniazzi F, et al. Among authors: tato l. Bone Miner. 1993 May;21(2):151-6. doi: 10.1016/s0169-6009(08)80017-7. Bone Miner. 1993. PMID: 8358252

6

Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.

Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Mengarda F, Pietrobelli A, Tatò L. Antoniazzi F, et al. Among authors: tato l. J Clin Endocrinol Metab. 2003 Mar;88(3):1096-101. doi: 10.1210/jc.2002-021154. J Clin Endocrinol Metab. 2003. PMID: 12629090 Free article. Clinical Trial.

7

Osteogenesis imperfecta and its molecular diagnosis by determination of mutations of type I collagen genes.

Tedeschi E, Antoniazzi F, Venturi G, Zamboni G, Tatò L. Tedeschi E, et al. Among authors: tato l. Pediatr Endocrinol Rev. 2006 Sep;4(1):40-6. Pediatr Endocrinol Rev. 2006. PMID: 17021582 Review.

8

Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.

Antoniazzi F, Bertoldo F, Mottes M, Valli M, Sirpresi S, Zamboni G, Valentini R, Tató L. Antoniazzi F, et al. Among authors: tato l. J Pediatr. 1996 Sep;129(3):432-9. doi: 10.1016/s0022-3476(96)70077-x. J Pediatr. 1996. PMID: 8804334

9

Osteogenesis imperfecta: practical treatment guidelines.

Antoniazzi F, Mottes M, Fraschini P, Brunelli PC, Tatò L. Antoniazzi F, et al. Among authors: tato l. Paediatr Drugs. 2000 Nov-Dec;2(6):465-88. doi: 10.2165/00128072-200002060-00005. Paediatr Drugs. 2000. PMID: 11127846 Review.

10

Osteogenesis imperfecta: clinical, biochemical and molecular findings.

Venturi G, Tedeschi E, Mottes M, Valli M, Camilot M, Viglio S, Antoniazzi F, Tatò L. Venturi G, et al. Among authors: tato l. Clin Genet. 2006 Aug;70(2):131-9. doi: 10.1111/j.1399-0004.2006.00646.x. Clin Genet. 2006. PMID: 16879195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters